|Phase of Study:||Phase II|
|Treatment Location:||Only at MDACC|
|Estimated Length of Stay in Houston:||Hospitalization is not required for this study.|
|Return Visit:||Patients must come to MDACC every two weeks for Avastin infusion.|
|Home Care:||Patient will take erlotinib orally on a daily basis at home.|
Study tests and evaluations will be performed at MDACC.